Resultados de la búsqueda 41-50 of 5024 for Incidence

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to evaluate different strategies of cardiovascular therapy with Carvedilol, aiming to reduce the incidence of left ventricular ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... incidence of secondary acute effects attributable to radiotherapy including incidence of PEG tube placement, duration and dose of narcotic analgesia ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   ... incidence of second primary CSCC tumors (SPTs) after surgery and RT; to evaluate the safety of adjuvant cemiplimab and that of placebo in high-risk CSCC ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... incidence of secondary acute effects attributable to radiotherapy including incidence of PEG tube placement, duration and dose of narcotic analgesia ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... incidence of secondary acute effects attributable to radiotherapy including incidence of PEG tube placement, duration and dose of narcotic analgesia ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... incidence of secondary acute effects attributable to radiotherapy including incidence of PEG tube placement, duration and dose of narcotic analgesia ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   ... incidence of second primary CSCC tumors (SPTs) after surgery and RT; to evaluate the safety of adjuvant cemiplimab and that of placebo in high-risk CSCC ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... incidence of second primary CSCC tumors (SPTs) after surgery and RT; to evaluate the safety of adjuvant cemiplimab and that of placebo in high-risk CSCC ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...